RAReem Ameen

Reem Ameen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Reem Ameen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Abdulaziz Al‐Bashir

    From the Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, and the Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait; and Kuwait Central Blood Bank, Ministry of Health, Kuwait

    3 shared publications
  • Rafiq I. Chowdhury

    From the Medical Laboratory Sciences Department and the Health Information and Administration Department, Faculty of Allied Health Sciences, and the Medicine Department, Faculty of Medicine, Kuwait University, Kuwait; and the Kuwait Central Blood Bank, Ministry of Health, Kuwait

    2 shared publications
  • Salem Al Shemmari

    2 shared publications
  • Salem Al‐Shemmari

    From the Medical Laboratory Sciences Department and the Health Information and Administration Department, Faculty of Allied Health Sciences, and the Medicine Department, Faculty of Medicine, Kuwait University, Kuwait; and the Kuwait Central Blood Bank, Ministry of Health, Kuwait

    2 shared publications
  • Abdulaziz Al-Bashir

    1 shared publication
  • Amani Albassami

    Kuwait Cancer Registry, HMJ Cancer Center, Kuwait, Kuwait

    1 shared publication

Latest Publications

  • Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups

    by Reem Ameen, Kamlesh P. Sajnani, Amani Albassami, Samar Refaat

    There is a wide variation in the prevalence of various subtypes of non-Hodgkin’s lymphoma worldwide. The aim of this study was to determine the relative frequency of different subtypes of non-Hodgkin’s lymphoma in Kuwait based on the Revised European–American Lymphoma (REAL) classification. From 1998 to 2006, 738 subjects were included that were registered with non-Hodgkin’s lymphoma in the population-based cancer registry at the Kuwait Cancer Control Center. Expert pathologists reviewed histological slides from all subjects. We performed detailed immunohistochemical studies and classified subjects based on the REAL classification. The prevalence of different types of non-Hodgkin's lymphoma was determined based on age, sex, site of disease, and ethnicity. Ethnicity groups comprised Kuwaiti Arabs, non Kuwaiti Arabs, Asians, and others. The prevalence of B- and T-cell lymphomas was 81.8% and 14.2%, respectively. The most common age group was 41–60 years old. The three most common subtypes in Kuwaiti Arabs were diffuse large B-cell lymphoma (46.5%), follicular lymphoma (15.5%), and mycosis fungoides (9.3%). In non-Kuwaiti Arabs, the most common subtypes were diffuse large B-cell lymphoma (48%), B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia (15.8%), and follicular lymphoma (12.7%). Overall, non-Kuwaiti Arabs exhibited the highest prevalence (59%), and 54% of all cases had extranodal presentation. Compared to the Western world, Kuwait had a lower prevalence of follicular lymphoma, a higher prevalence of diffuse large B-cell lymphoma and extranodal presentation, and a high frequency of mycosis fungoides. Compared to other parts of Asia, Kuwait had a lower frequency of peripheral T-cell lymphomas.


  • Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion

    by Reem Ameen, Salem Al Shemmari, Abdulaziz Al‐Bashir

    BACKGROUND: Sickle cell disease (SCD) is common in the Arabian Gulf region. Most cases require a red blood cell (RBC) transfusion, increasing the potential for RBC alloantibody development. The incidence of RBC alloimmunization among Kuwaiti Arab SCD patients is not yet known. This study retrospectively assessed the effect of using two different matching protocols on the incidence of alloimmunization among multiply transfused Kuwaiti Arab SCD patients.STUDY DESIGN AND METHODS: A total of 233 Kuwaiti Arab SCD patients were divided into two groups: Group 1 (n = 110) received RBC transfusion through standard ABO‐ and D‐matched nonleukoreduced blood; Group 2 (n = 123) received RBCs matched for ABO, Rh, and K1 poststorage‐leukoreduced blood. Multivariate analysis was performed on the factors associated with RBC alloimmunization and antibody specificity.RESULTS: Sixty‐five percent of patients in Group 1 developed clinically significant RBC alloantibody with an increased prevalence in females; in patients in Group 2, 23.6% developed RBC alloantibodies (p = 0.01). In Group 1, 72 patients (65.5%) had alloantibodies directed against Rh and Kell systems (p = 0.01). Multivariate analysis further confirmed the results, showing that blood transfusion type and sex have significant effects on the rate of alloimmunizations.CONCLUSION: This study confirms the importance of selecting RBCs matched for Rh and Kell to reduce the risk of alloimmunizations among Kuwaiti Arab SCD patients.


  • Prevalence of viral markers among first‐time Arab blood donors in Kuwait

    by Reem Ameen, Nabil Sanad, Salem Al‐Shemmari, Iqbal Siddique, Rafiq I. Chowdhury, Samia Al‐Hamdan, Abdulaziz Al‐Bashir

    BACKGROUND: The aim of this study was to assess the effect of blood donation modes on the prevalence of viral markers among Arab first‐time blood donors in Kuwait.STUDY DESIGN AND METHODS: Donor ethnic background was classified as Kuwaiti nationals and non‐Kuwaiti Arabs. A total of 26,874 donors were screened in 2002 for the following viral markers: hepatitis C virus antibody (anti‐HCV), hepatitis B surface antigen (HBsAg), anti‐hepatitis B core antigen (HBc), human immunodeficiency virus‐1 and ‐2 antibody (anti‐HIV‐1 and ‐2), HIV p24, and human T lymphotropic virus‐I and ‐II antibody (anti‐HTLVI/II). All samples positive for the presence of anti‐HBc were tested for anti‐HBs. Among these donors, 12,798 were first‐time donors of which 74 percent were replacement and 26 percent were volunteers.RESULTS: The prevalence of HCV among replacement donors was significantly higher than the volunteer group. The difference between the two modes of blood donations, however, was not significant for HBsAg. The prevalence of anti‐HCV among Kuwaiti national and non‐Kuwaiti Arab first‐time donors was 0.8 and 5.4 percent, respectively, whereas the prevalence of HBsAg was 1.1 and 3.5 percent, respectively, with the difference being significant at a p level of CONCLUSION: A high prevalence of HBV and HCV was found among non‐Kuwaiti Arab donors. The prevalence of anti‐HCV was only significantly higher among replacement versus volunteer first‐time donors. Therefore, there is a need to develop a strategic plan that incorporates the diverse background of the blood donors living in Kuwait.


  • Frequency of Red Blood Cell Alloantibody in Kuwaiti Population

    by Reem Ameen, Ohood Al-Eyaadi, Salem Al-Shemmari, Rafiqul Chowdhury, Abdulaziz Al-Bashir

    Objective: The aim of this study was to analyze the alloimmunization against red blood cells (RBC) among Kuwaiti population. Materials and Methods: Retrospective analysis of RBC alloimmunization among 179,045 Kuwaiti patients, pregnant women, and allogeneic blood donors was conducted for the period of 1992–2001. The frequency of 24 alloantibody specificities from 1,278 alloimmunized Kuwaitis was estimated. Results: The prevalence of positive antibody screen in Kuwait was 0.49%.The five most frequently identified alloantibodies were anti-D (27.3%), anti-E (18.5%), anti-K (15.6%), anti-Lea (8.7%), and anti-Leb (6.6%). Frequency of alloimmunization was greater among Kuwaiti female than male patients (3.2 F to 1 M). Anti-D (p < 0.001), anti-E (p = 0.05), anti-K (p = 0.04) were also more frequently identified alloantibody among Kuwaiti females. Conclusion: The results show higher predominance of RBC alloimmunization in females than males. Anti-D, anti-E, and anti-K were the most common clinically significant alloantibodies identified in the Kuwaiti population and were also more frequent among Kuwaiti females.


  • RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

    by Reem Ameen, Salem Al‐Shemmari, Salah Al‐Humood, Rafiq I. Chowdhury, Ohood Al‐Eyaadi, Abdulaziz Al‐Bashir

    BACKGROUND:  Thalassemia major is a common hemoglobinopathy in the Arabian Gulf region. However, limited data are available on the frequency of RBC alloimmunization and autoimmunization in transfusion‐dependent Arab thalassemia patients.STUDY DESIGN AND METHODS:  A total of 190 thalassemia major patients were classified as Kuwaiti Arab and non‐Kuwaiti Arab. Pretransfusion investigation records were reviewed for the presence of RBC alloantibody and autoantibody, and the age at which RBC alloantibody was developed.RESULTS:  Fifty‐seven (30%) patients developed RBC alloantibodies. The most common clinically significant alloantibodies were directed against antigens in the Kell and Rh systems. Anti‐K developed in 41 (72%) patients followed by anti‐E in 26 (45.6%). RBC autoantibodies developed in 21 (11%) patients with and without underlying RBC alloantibodies. Sixty‐six (49.6%) RBC alloantibodies developed between the ages of 2 and 10 years.CONCLUSION:  Several factors might have contributed to the high alloimmunization and autoimmunization rate observed in this study, including the heterogeneity of the population living in Kuwait, lack of better‐matched donors for those patients, and the use of poststorage leukodepleted blood. It is recommended that thalassemia patients receive blood matched for Rh and Kell antigens and prestorage leukodepleted RBCs.